Virtus ETF Advisers LLC Revolution Medicines, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 2,321 shares of RVMD stock, worth $131,066. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,321

Previous 2,278 1.89%

Holding current value

$131,066

Previous $88,000 19.32%

% of portfolio

0.05%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $1,587 - $2,061	43 Added 1.89%	2,321 $105,000
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $31,134 - $42,022	-1,033 Reduced 31.2%	2,278 $88,000
Q1 2024 May 15, 2024	SELL	$26.56 - $33.55 $6,082 - $7,682	-229 Reduced 6.47%	3,311 $106,000
Q4 2023 Feb 15, 2024	SELL	$18.35 - $34.12 $6,899 - $12,829	-376 Reduced 9.6%	3,540 $101,000
Q3 2023 Nov 07, 2023	SELL	$25.17 - $35.05 $9,816 - $13,669	-390 Reduced 9.06%	3,916 $108,000
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $2,778 - $3,699	137 Added 3.29%	4,306 $115,000
Q1 2023 May 15, 2023	SELL	$20.76 - $30.09 $33,257 - $48,204	-1,602 Reduced 27.76%	4,169 $90,000
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $7,832 - $11,309	-443 Reduced 7.13%	5,771 $137,000
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $785 - $1,170	45 Added 0.73%	6,214 $123,000
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $2,995 - $5,597	-206 Reduced 3.23%	6,169 $120,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $6,422 - $9,794	-371 Reduced 5.5%	6,375 $163,000
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $14,512 - $20,085	596 Added 9.69%	6,746 $170,000
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $7,687 - $10,724	-321 Reduced 4.96%	6,150 $169,000
Q2 2021 Aug 10, 2021	SELL	$29.0 - $47.44 $13,166 - $21,537	-454 Reduced 6.56%	6,471 $205,000
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $4,465 - $6,531	120 Added 1.76%	6,925 $318,000
Q4 2020 Feb 12, 2021	SELL	$30.19 - $45.49 $52,319 - $78,834	-1,733 Reduced 20.3%	6,805 $269,000
Q3 2020 Nov 13, 2020	SELL	$22.61 - $34.8 $26,295 - $40,472	-1,163 Reduced 11.99%	8,538 $297,000
Q2 2020 Aug 05, 2020	BUY	$19.65 - $39.34 $190,624 - $381,637	9,701 New	9,701 $306,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Revolution Medicines, Inc. Transaction History